The results demonstrated that GLP-1R activation with liraglutide dose-dependently suppressed Akt activation and tumourigenicity/metastasis in human pancreatic cancer cells both in vitro and in vivo (70). This evidence concerns the gene GLP1R and familial pancreatic carcinoma.